DOCSLIB.ORG

Web Opens New World of Drugs for Kids the Four Most Seriously Affec- REBECCA URBAN “But It’S Tended to Be Older Ted Boys Are Believed to Have Been JAMIE WALKER People

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Web Opens New World of Drugs for Kids the Four Most Seriously Affec- REBECCA URBAN “But It’S Tended to Be Older Ted Boys Are Believed to Have Been JAMIE WALKER People 24 Feb 2018 Weekend Australian, Australia Author: Rebecca Urban Jamie Walker • Section: General News Article Type: News Item • Audience : 219,242 • Page: 5 • Printed size: 294.00cm² Market: National • Country: Australia • ASR: AUD 9,601 • words: 627 Item ID: 916681320 Licensed by Copyright Agency. You may only copy or communicate this work with a licence. Page 1 of 1 Web opens new world of drugs for kids The four most seriously affec- REBECCA URBAN “But it’s tended to be older ted boys are believed to have been JAMIE WALKER people. The fact that we’ve now seen 14- and 15-year-olds — intubated before being admitted whose brains are still developing The internet and its shadier side- to intensive care. All are expected — doing it is really confronting kick, the darkweb, are dramati- to make a full recovery, and only and frightening. cally altering drug use among one remains in hospital. “Things are changing so quick- young people, providing around- ly. And, with technology in the the-clock worldwide access to a A class of drug known as a picture, kids are always two steps wide range of drugs, chemicals nootropic, or a “smart drug”, ahead.” and supplements and creating a phenibut is designed to enhance conundrum for authorities, edu- brain function and elevate mood. AIMING HIGH It has no stimulatory effects and is cators and policymakers. Prevalence (%) or drug This week’s alarming case on often used by anxiety sufferers as a relaxant. Legal in Russia, it was use in the past year the Gold Coast, where seven Year among students aged 12 to 17 10 students overdosed while at available online until the TGA 13.6 school, has baffled drug experts for declared it prohibited in Australia. CannabisCa a range of reasons. Monica Barratt, a research fel- TrTranquilisers 12 The substance involved — low with the National Drug and InInhalants 11.4 thought to be a Russian drug Alcohol Research Centre, said EcEcstasy 2.6 phenibut was not typically associ- HHallucinogens 2.2 called phenibut that, until a ated with high-risk drug-taking AAmphetamines 1.9 Therapeutic Goods Administra- behaviour. StSteroids 1.8 tion clampdown earlier this “But if there is this generational CoCocaine 1.4 month, was readily available on- move away from getting high, OOpiates 1.1 line — is not a household name. drunk or messy, we could be see- 2014 data Source: DARTA But recent evidence suggests ing a move towards drugs with teenagers are increasingly turning other motivations,” she said. to over-the-counter pharma- ceuticals, such as paracetamol and According to the Australian ibuprofen, often mixing them with Secondary Students’ Alcohol and other drugs or alcohol in order to Drug survey released in 2016, get high. minors are drinking and smoking “It’s a whole new world,” says less than they did 20 years ago. one former Gold Coast principal. The use of opiates, such as heroin “If a kid gets caught with pot, and morphine, has also fallen, they are excluded, it’s simple. But while cocaine and ecstasy use, if a kid gets caught with an antide- although uncommon, has re- pressant or sleeping pills … I don’t mained stable. know. This is not an area schools Among 12- to 17-year-olds, can- are ready for.” nabis is the most commonly used illicit drug, with 13.6 per cent While the exact circumstances reporting having used it in the pre- are still under investigation, St vious year, followed by tranquillis- Stephen’s College principal Jamie ers (12 per cent) and inhalants Dorrington said a teacher had (11.4 per cent). But the study did noticed several boys were “not not canvas young people on their concentrating” on Wednesday illicit use of over-the-counter or morning and escorted them to the prescription medicines. school’s health centre. The first call to the emergency Drug and Alcohol Research services went out at 12.47pm. The and Training Australia director symptoms varied, depending on Paul Dillon said the use of the how much of the powdered sub- internet and social media to access stance had been ingested. One boy drugs was a trend that warranted was lapsing in and out of con- attention. “We are entering a new sciousness, and ambulance offi- era of accessibility to these sub- cers put him on oxygen to stances, where people are order- maintain respiration. Others were ing online and getting them disorientated or nauseous. through the post,” he said..
Load more

Recommended publications
  • Phenibut Overdose in Combination with Fasoracetam: Emerging Drugs of Abuse
    Open Access Journal of Clinical Intensive Care and Medicine Case Report Phenibut Overdose in Combination ISSN with Fasoracetam: Emerging Drugs 2639-6653 of Abuse Cristian Merchan1*, Ryan Morgan1, John Papadopoulos1,2 and David Fridman2 1Department of Pharmacy, New York University Langone Medical Center, New York, USA 2New York University School of Medicine, New York, USA *Address for Correspondence: Dr. Cristian INTRODUCTION D Merchan, Pharm.D, BCCCP, Critical Care Pharmacotherapist, Department of Pharmacy, The widespread availability of non-traditional dietary supplements and New York University Langone Medical Center, pharmacologically active substances via the Internet continues to introduce New York, USA, Tel: 516-263-1671; Email: [email protected] mechanisms for inadvertent toxidromes not commonly seen. Consumers are virtually unrestricted in their ability to acquire products purporting augmentation of normal Submitted: 25 October 2016 Approved: 15 December 2016 physiology for the purposes of enhancement, recreation, and/or potential abuse. The Published: 17 December 2016 safety proiles at standard or toxic doses remain largely unknown for many agents that Copyright: 2016 Merchan et al. This is an can be purchased electronically. We report a case of mixed toxicity related to phenibut open access article distributed under the and fosaracetam, both of which are readily available for consumer purchase from Creative Commons Attribution License, which online retailers. Written and verbal consent was obtained for this case presentation. permits unrestricted use, distribution, and reproduction in any medium, provided the CASE REPORT original work is properly cited. Keywords: Nootropic; GABA agonist; Drug of A 27-year-old male with a past medical history of anxiety was discovered abuse; Dietary supplement; Alternative medicine unresponsive on the sidewalk.
    [Show full text]
  • Conjugation of Tryptamine to Biologically Active Carboxylic Acids in Order to Create Prodrugs
    ISSN 2380-5064 | The Arsenal is published by the Augusta University Libraries | http://guides.augusta.edu/arsenal Volume 4, Issue 1 (2021) Special Edition Issue CONJUGATION OF TRYPTAMINE TO BIOLOGICALLY ACTIVE CARBOXYLIC ACIDS IN ORDER TO CREATE PRODRUGS Colin Miller, Jr. and Iryna O. Lebedyeva Citation Miller, C., Jr., & Lebedyeva, I. O. (2021). Conjugation of tryptamine to biologically active carboxylic acids in order to create prodrugs. The Arsenal: The Undergraduate Research Journal of Augusta University, 4(1), 26. http://doi.org/10.21633/issn.2380.5064/s.2021.04.01.26 © Miller, Jr. and Lebedyeva 2021. This open access article is distributed under a Creative Commons Attribution NonCommercial-NoDerivs 2.0 Generic License (https://creativecommons.org/licenses/by-nc-nd/2.0/). Conjugation of Tryptamine to Biologically Active Carboxylic Acids in Order to Create Prodrugs Presenter(s): Colin Miller, Jr. Author(s): Colin Miller Jr. and Iryna O. Lebedyeva Faculty Sponsor(s): Iryna O. Lebedyeva, PhD Affiliation(s): Department of Chemistry and Physics (Augusta Univ.) ABSTRACT A number of blood and brain barrier penetrating neurotransmitters contain polar functional groups. Gamma-aminobutyric acid (GABA) is an amino acid, which is one of the primary inhibitory neurotransmitter in the brain and a major inhibitory neurotransmitter in the spinal cord. Antiepileptic medications such as Gabapentin, Phenibut, and Pregabalin have been developed to structurally represent GABA. These drugs are usually prescribed for the treatment of neuropathic pain. Since these drugs contain a polar carboxylic acid group, it affects their ability to penetrate the blood and brain barrier. To address the low bioavailability and tendency for intramolecular cyclization of Gabapentin, its less polar prodrug Gabapentin Enacarbil has been approved in 2011.
    [Show full text]
  • 4Th Quarter 2020 DEA
    QUARTERLY REPORT 4th Quarter – 2020 U.S. Department of Justice Drug Enforcement Administration Diversion Control Division Drug and Chemical Evaluation Section Drug Enforcement Administration – Toxicology Testing Program Contents Introduction ............................................................ 3 Summary ................................................................. 4 NPS Discovered via DEA TOX ................................. 5 New Psychoactive Substances ............................... 6 Traditional Illicit Drugs ........................................... 8 Prescription and Over the Counter Drugs ............. 9 Contact Information ............................................. 10 2 | Page 4th Quarter Report – 2020 Drug Enforcement Administration – Toxicology Testing Program Introduction The Drug Enforcement Administration’s Toxicology Testing Program (DEA TOX) began in May 2019 as a surveillance program aimed at detecting new psychoactive substances within the United States. In response to the ongoing synthetic drug epidemic, the Drug Enforcement Administration (DEA) awarded a contract with the University of California at San Francisco (UCSF) to analyze biological samples generated from overdose victims of synthetic drugs. In many cases, it can be difficult to ascertain the specific substance responsible for the overdose. The goal of DEA TOX is to connect symptom causation to the abuse of newly emerging synthetic drugs (e.g. synthetic cannabinoids, synthetic cathinones, fentanyl-related substances, other hallucinogens, etc.).
    [Show full text]
  • Newer Unregulated Drugs Look-Up Table
    Newer Unregulated Drugs Look-up Table List Name Chemical Name/AKA Type of drug Notes Stimulant Regulation under MDA (Sch. 1 or TCDO) Stimulant/Hallucinogen Regulation under MDA (Sch. 2-5) Hallucinogen Regulated by PSA Depressant Exempt Cannabinoid Uncertain/requires clarification 1P-LSD 1-propionyl-lysergic acid diethylamide Hallucinogen An LSD analogue that side-stepped MDA and was on sale as an NPS; now covered by the PSA. 2-AI 2-Aminoindane Stimulant, amphetamine analogue Reported in the UK in 2011 by the Forensic Early 2-MAI N-methyl-2-Aminoindane Warning System (FEWS). Had been on sale via number MMAI of online stores; covered by PSA. 2-MeO-ketamine Methoxyketamine Related to methoxetamine so a relative Believed to have been made a CD at the same time as Methoxieticyclidine of ketamine – i.e. a dissassociative Methoxetamine anaesthetic hallucinogen 2C-B-BZP (1-(4-bromo-2,5- Piperazine family; stimulant Class B dimethoxybenzyl)piperazine) 2-DPMP Desoxypipadrol stimulant Strong and long acting stimulant; reported duration of 2-diphenylmethylpiperidine effect 24-28hrs or more and effective at very low doses. Had been on sale in the UK and cropped up in branded “Ivory Wave” and in other compounds. Linked to fatalities. Class B, Sch1. 2-NE1 APICA Synthetic cannabinoid receptor agonist 3rd generation SCRA. Covered by PSA SDB-001 N-(1-adamantyl)-1-pentyl-1H-indole-3- carboxamide 3-FPM Phenzacaine Stimulant, euphoriants Sibling of the controlled drug Phenmetrazine. Emerged PAL-593 2015. Covered by PSA 2-(3-fluorophenyl)-3-methylmorpholine 3-hydroxyphenazepam Benzo, GABA-nergic PSA 3-MeO-PCE (3-methoxyeticyclidine) Related to methoxetamine so a relative Probably regulated under the same clause that made of ketamine – i.e.
    [Show full text]
  • 2016-11-BMF-83 Antidepressants
    Antidepressants BMF 83 - Antidepressants BMF 83 - Antidepressants Depression is a common psychiatric disorder impacting millions of people worldwide. It is caused by an imbalance of chemicals 1 in the brain, namely serotonin and noradrenaline . Everyone experiences highs and lows, but depression is characterised by 2 persistent sadness for weeks or months . With depression there is lasting feeling of hopelessness, often accompanied by anxiety. Sufferers lose interest in things that they previously enjoyed, and experience bouts of tearfulness. Rational thinking and decision 2 making are impacted. Physical manifestations include tiredness, insomnia, loss of appetite and sex drive, aches and pains . At its worst depression can cause the sufferer to feel suicidal. Depression is usually treated with a combination of counselling and drug therapy. There is also evidence that exercise can help depression. Most people with moderate or severe depression benefit from antidepressant medication. There are a wide range of 3 antidepressants on the market, which can be broadly divided according to mechanism of action ; • Selective serotonin reuptake inhibitors (SSRIs) • Serotonin-norepinephrine reuptake inhibitors (SNRIs) • Serotonin modulator and stimulators (SMSs) • Serotonin antagonist and reuptake inhibitors (SARIs) • Norepinephrine reuptake inhibitors (NRIs or NERIs) • Tetracyclic antidepressants (TeCAs) • Tricyclic antidepressants (TCAs) • Monoamine oxidase inhibitors (MAOIs) www.chiron.no | E-mail: [email protected] | Tel.: +47 73 87 44 90 | Fax.: +47 73 73 87 44 99 | BMF 83 p.1/8 , 10_16 BMF 83 - Antidepressants BMF 83 - Antidepressants 1 Today the most common first choice of medication is a SSRI , i.e. Citalopram, Escitalopram, Fluvoxamine, Paroxetine, Sertraline, Fluoxetine. Antidepressants are not addictive, but can result in withdrawal symptoms when therapy is stopped.
    [Show full text]
  • Effects of Neuroactive Amino Acids Derivatives on Cardiac and Cerebral Mitochondria and Endothelial Functions in Animals Exposed to Stress T
    Effects of Neuroactive Amino Acids Derivatives on Cardiac and Cerebral Mitochondria and Endothelial functions in Animals Exposed to Stress T. A. Popova, I. I. Prokofiev, I. S. Mokrousov, V. N. Perfilova, A. V. Borisov, S. A. Lebedeva, G. P. Dudchenko, I. N. Tyurenkov, O. V. Ostrovsky Volgograd State Medical University, Volgograd, Russia Received ABSTRACT 22nd May 2017 Received in revised form rd Introduction: To study the effects of glufimet, a new derivative of glutamic acid, and 3 November 2017 phenibut, a derivative of γ-aminobutyric acid (GABA), on cardiac and cerebral mitochondria Accepted and endothelial functions in animals following exposure to stress and inducible nitric oxide st 21 December 2017 synthase (iNOS) inhibition. Methods: Rats suspended by their dorsal cervical skin fold for 24 hours served as the immobilization and pain stress model. Arterial blood pressure was determined using a non-invasive blood pressure monitor. Mitochondrial fraction of heart and Corresponding author: brain homogenates were isolated by differential centrifugation and analysed for mitochondrial Dr. V. N. Perfilova, respiration intensity, lipid peroxidation (LPO) and antioxidant enzyme activity using Volgograd State Medical University, polarographic method. The concentrations of nitric oxide (NO) terminal metabolites were measured using Griess reagent. Hemostasis indices were evaluated. Platelet aggregation Volgograd, Russia was estimated using modified version of the Born method described by Gabbasov et al., Tel: 8(8442)97-81-80 1989. Results: The present study demonstrated that stress leads to an elevated Fax: 8(8442)97-81-80 concentration of NO terminal metabolites and LPO products, decreased activity of antioxidant Email: [email protected] enzymes, reduced mitochondrial respiratory function, and endothelial dysfunction.
    [Show full text]
  • Pharmacology
    STATE ESTABLISHMENT «DNIPROPETROVSK MEDICAL ACADEMY OF HEALTH MINISTRY OF UKRAINE» V.I. MAMCHUR, V.I. OPRYSHKO, А.А. NEFEDOV, A.E. LIEVYKH, E.V.KHOMIAK PHARMACOLOGY WORKBOOK FOR PRACTICAL CLASSES FOR FOREIGN STUDENTS STOMATOLOGY DEPARTMENT DNEPROPETROVSK - 2016 2 UDC: 378.180.6:61:615(075.5) Pharmacology. Workbook for practical classes for foreign stomatology students / V.Y. Mamchur, V.I. Opryshko, A.A. Nefedov. - Dnepropetrovsk, 2016. – 186 p. Reviewed by: N.I. Voloshchuk - MD, Professor of Pharmacology "Vinnitsa N.I. Pirogov National Medical University.‖ L.V. Savchenkova – Doctor of Medicine, Professor, Head of the Department of Clinical Pharmacology, State Establishment ―Lugansk state medical university‖ E.A. Podpletnyaya – Doctor of Pharmacy, Professor, Head of the Department of General and Clinical Pharmacy, State Establishment ―Dnipropetrovsk medical academy of Health Ministry of Ukraine‖ Approved and recommended for publication by the CMC of State Establishment ―Dnipropetrovsk medical academy of Health Ministry of Ukraine‖ (protocol №3 from 25.12.2012). The educational tutorial contains materials for practical classes and final module control on Pharmacology. The tutorial was prepared to improve self-learning of Pharmacology and optimization of practical classes. It contains questions for self-study for practical classes and final module control, prescription tasks, pharmacological terms that students must know in a particular topic, medical forms of main drugs, multiple choice questions (tests) for self- control, basic and additional references. This tutorial is also a student workbook that provides the entire scope of student’s work during Pharmacology course according to the credit-modular system. The tutorial was drawn up in accordance with the working program on Pharmacology approved by CMC of SE ―Dnipropetrovsk medical academy of Health Ministry of Ukraine‖ on the basis of the standard program on Pharmacology for stomatology students of III - IV levels of accreditation in the specialties Stomatology – 7.110105, Kiev 2011.
    [Show full text]
  • Phenibut (4-Amino-3-Phenyl-Butyric Acid): Availability, Prevalence of Use, Desired Effects and Acute Toxicity
    bs_bs_banner REVIEW Drug and Alcohol Review (2015) DOI: 10.1111/dar.12356 Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity DAVID R. OWEN1,DAVIDM.WOOD2,3,JOHNR.H.ARCHER2 & PAUL I. DARGAN2,3 1Division of Brain Sciences, Imperial College London, London, UK, 2Clinical Toxicology, Guy’s and St Thomas’ NHS Foundation Trust and King’s Health Partners, London, UK, and 3Faculty of Life Sciences and Medicine, King’sCollege London, London, UK Abstract Introduction and Aims. There has been a global increase in the availability and use of novel psychoactive substances (NPS) over the last decade. Phenibut (β-phenyl-γ-aminobutyric acid) is a GABAB agonist that is used as an NPS. Here, we bring together published scientific and grey information sources to further understand the prevalence of use, desired effects and acute toxicity of phenibut. Design and Methods. Using European Monitoring Centre for Drugs and Drug Addiction Internet snapshot method- ology, we undertook an English language Internet snapshot survey in May 2015 to gather information on the availability and price of phenibut from Internet NPS retailers. To gather information on prevalence of use, desired effects and/or adverse effects, we searched grey literature (online drug discussion forums) and medical literature (PubMed and abstracts from selected International Toxicology conferences). Results. We found 48 unrelated Internet suppliers selling phenibut in amounts ranging from 5 g (US$1.60, £1.01/g) to 1000 kg (US$0.23, £0.14/g). Capsules containing 200–500 mg of phenibut were available in packs of between 6 (US$4.45, £2.80/g) and 360 (US$0.43, £0.27/g).
    [Show full text]
  • The Toxicology Investigators Consortium Case Registry—The 2019 Annual Report
    Journal of Medical Toxicology https://doi.org/10.1007/s13181-020-00810-7 ORIGINAL ARTICLE The Toxicology Investigators Consortium Case Registry—the 2019 Annual Report Meghan B. Spyres1,2 & Lynn A. Farrugia3 & A. Min Kang2,4 & Kim Aldy5,6 & Diane P. Calello7 & Sharan L. Campleman6 & Shao Li6 & Gillian A Beauchamp8 & Timothy Wiegand9 & Paul M. Wax5,6 & Jeffery Brent10 & On behalf of the Toxicology Investigators Consortium Study Group Received: 6 August 2020 /Revised: 21 August 2020 /Accepted: 21 August 2020 # American College of Medical Toxicology 2020 Abstract The Toxicology Investigators Consortium (ToxIC) Registry was established by the American College of Medical Toxicology (ACMT) in 2010. The Registry collects data from participating sites with the agreement that all bedside medical toxicology consultation will be entered. This tenth annual report summarizes the Registry’s 2019 data and activity with its additional 7177 cases. Cases were identified for inclusion in this report by a query of the ToxIC database for any case entered from 1 January to 31 December 2019. Detailed data was collected from these cases and aggregated to provide information which included demo- graphics, reason for medical toxicology evaluation, agent and agent class, clinical signs and symptoms, treatments and antidotes administered, mortality, and whether life support was withdrawn. 50.7% of cases were female, 48.5% were male, and 0.8% were transgender. Non-opioid analgesics was the most commonly reported agent class, followed by opioid and antidepressant classes. Acetaminophen was once again the most common agent reported. There were 91 fatalities, comprising 1.3% of all Registry cases. Major trends in demographics and exposure characteristics remained similar to past years’ reports.
    [Show full text]
  • WO 2017/172603 Al 5 October 2017 (05.10.2017) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/172603 Al 5 October 2017 (05.10.2017) P O P C T (51) International Patent Classification: c/o Tioga Research, Inc., 6330 Nancy Ridge Drive, Suite A61K 31/197 (2006.01) A61K 31/00 (2006.01) 102, San Diego, California 92121 (US). A61K 9/00 (2006.01) A61K 31/195 (2006.01) (74) Agents: TANNER, Lorna L. et al; SHEPPARD MUL- A61K 9/06 (2006.01) LIN RICHTER & HAMPTON LLP, 379 Lytton Avenue, (21) International Application Number: Palo Alto, California 94301-1479 (US). PCT/US20 17/024281 (81) Designated States (unless otherwise indicated, for every (22) International Filing Date: kind of national protection available): AE, AG, AL, AM, 27 March 2017 (27.03.2017) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, (25) Filing Language: English DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (26) Publication Language: English HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, (30) Priority Data: MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, 62/390,369 28 March 2016 (28.03.2016) US NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, (71) Applicant: TIOGA RESEARCH, INC. [US/US]; 6330 RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, Nancy Ridge Drive, Suite 102, San Diego, California TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, 9212 1 (US).
    [Show full text]
  • Continuous Flow Synthesis of a (S)-Pregabalin Precursor and (S)-Warfarin
    Symmetry 2015, 7, 1395-1409; doi:10.3390/sym7031395 OPEN ACCESS symmetry ISSN 2073-8994 www.mdpi.com/journal/symmetry Article Enantioselective Organocatalysis in Microreactors: Continuous Flow Synthesis of a (S)-Pregabalin Precursor and (S)-Warfarin Riccardo Porta, Maurizio Benaglia *, Francesca Coccia, Sergio Rossi and Alessandra Puglisi * Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, Milano I-20133, Italy; E-Mails: [email protected] (R.P.); [email protected] (F.C.); [email protected] (S.R.) * Authors to whom correspondence should be addressed; E-Mails: [email protected] (M.B.); [email protected] (A.P.); Tel.: +39-02-5031-4171 (M.B.); +39-02-5031-4189 (A.P.); Fax: +39-02-5031-4159 (M.B. & A.P.). Academic Editor: Svetlana Tsogoeva Received: 10 June 2015 / Accepted: 17 July 2015 / Published: 4 August 2015 Abstract: Continuous flow processes have recently emerged as a powerful technology for performing chemical transformations since they ensure some advantages over traditional batch procedures. In this work, the use of commercially available and affordable PEEK (Polyetheretherketone) and PTFE (Polytetrafluoroethylene) HPLC (High Performance Liquid Chromatography) tubing as microreactors was exploited to perform organic reactions under continuous flow conditions, as an alternative to the commercial traditional glass microreactors. The wide availability of tubing with different sizes allowed quickly running small-scale preliminary screenings, in order to optimize the reaction parameters, and then to realize under the best experimental conditions a reaction scale up for preparative purposes. The gram production of some Active Pharmaceutical Ingredients (APIs) such as (S)-Pregabalin and (S)-Warfarin was accomplished in short reaction time with high enantioselectivity, in an experimentally very simple procedure.
    [Show full text]
  • Phenibut Intoxication Alina Plavsky, MD, MPH Bailey Pope, MD Oregon Health & Science University
    Altered Mental Status Takes a New Form A Unique Case of Phenibut Intoxication Alina Plavsky, MD, MPH Bailey Pope, MD Oregon Health & Science University [ ] Case Presentation Hospital Course Discussion HPI: A 29-yo male presented to the emergency The patient initially presented with agitation, Phenibut (β-phenyl-γ-aminobutyric acid) is a GABAergic room with acute altered mental status. He was dystonia, hyperreflexia, mydriasis, and visual anxiolytic and cognition-enhancing supplement. It undergoing physical therapy at a rehabilitation hallucinations; then developed sedation and primarily acts at GABA-B receptors and to a lesser extent facilityDevelopment for an injured of a New ankle, Practice and Model his catatonia within a day. Agitation, insomnia, and GABA-A receptors. The pharmacological activity of medications were disbursed under supervision. psychosis recurred again, lasting for several days. There Phenibut is similar to baclofen. Although not approved for His stay was unremarkable until the evening was initially concern for anticholinergic toxicity; medicinal use in the United States, Phenibut is a potentially prior to his presentation, when he was found to however, he did not exhibit blurry vision, dry mouth, or dangerous supplement that is easily available online. be agitated, verbally abusive, and urinary retention consistent with the toxidrome. Sedation, dystonia, pupillary dilation, and agitated displaying odd limb posturing. Overdose or withdrawal arising from his prescribed delirium were intoxication symptoms noted in our case and medications was considered unlikely. He ultimately have been reported in several other case reports. Stupor, PMHx: Medications: required antipsychotics, benzodiazepines, and supportive hypothermia, nausea, and vomiting have also been • ADHD • Nortriptyline 25mg qhs care.
    [Show full text]